Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Articles published by Vanqua Bio
Vanqua Bio Announces Positive Interim Results from Phase 1 Clinical Trial of VQ-101, an Orally Administered, Brain-Penetrant, Allosteric Activator of GCase for the Treatment of GBA-Parkinson’s and Related Disorders
October 09, 2024
From
Vanqua Bio
Via
GlobeNewswire
Vanqua Bio to Participate in Upcoming Scientific Conferences
September 18, 2024
From
Vanqua Bio
Via
GlobeNewswire
Vanqua Bio to Present at Inaugural GBA1 2024 Meeting
June 20, 2024
From
Vanqua Bio
Via
GlobeNewswire
Vanqua Bio Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating VQ-101, its Small Molecule GCase Activator for GBA-Parkinson’s Disease and Related Disorders
April 09, 2024
From
Vanqua Bio
Via
GlobeNewswire
Vanqua Bio to Present at the Stifel 2024 CNS Days Conference
March 13, 2024
From
Vanqua Bio
Via
GlobeNewswire
Vanqua Bio to Present Pre-Clinical Data on VQ-101, a Novel GCase Activator For The Treatment of GBA-Parkinson’s Disease
February 27, 2024
From
Vanqua Bio
Via
GlobeNewswire
Vanqua Bio Advances Clinical Candidate for Parkinson’s Disease, Expands Leadership Team to Support Further Development
December 12, 2023
From
Vanqua Bio
Via
GlobeNewswire
Vanqua Bio to Participate in the Leerink Partners Biopharma Private Company Connect
October 18, 2023
From
Vanqua Bio
Via
GlobeNewswire
Vanqua Bio to Present at the Stifel 2023 CNS Day Conference
March 22, 2023
From
Vanqua Bio
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.